VYDUO Drug Patent Profile
✉ Email this page to a colleague
When do Vyduo patents expire, and what generic alternatives are available?
Vyduo is a drug marketed by Prinston Inc and is included in one NDA.
The generic ingredient in VYDUO is nebivolol hydrochloride; valsartan. There are fourteen drug master file entries for this compound. Additional details are available on the nebivolol hydrochloride; valsartan profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VYDUO?
- What are the global sales for VYDUO?
- What is Average Wholesale Price for VYDUO?
Summary for VYDUO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | VYDUO at DailyMed |
US Patents and Regulatory Information for VYDUO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | VYDUO | nebivolol hydrochloride; valsartan | TABLET;ORAL | 210596-001 | Sep 19, 2022 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
